| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Apogee Therapeutics, Inc. (APGE) has 10 insiders with recent SEC Form 4 filings, including 2 buys and 16 sells. APGE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.13M | $94.07M | - | |
| Dir | 365.9K | $30.38M | - | |
| Other | 228.3K | $18.95M | - | |
| CFO | 179.4K | $14.89M | - | |
| Dir | 14.5K | $1.20M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2025 | Dambkowski Carl51 | Chief Medical Officer | Sell | 2,725 | $35.75 | $97,418.75 | -1.1% | +8.8% | +132.2% | |
| Apr 2, 2025 | Dambkowski Carl51 | Chief Medical Officer | Sell | 3,860 | $36.22 | $139,801.27 | -0.5% | +17.0% | +122.9% | |
| Mar 5, 2025 | Dambkowski Carl51 | Chief Medical Officer | Sell | 1,590 | $30.48 | $48,463.20 | -0.6% | +18.0% | +125.8% | |
| Mar 5, 2025 | Henderson Michael Thomas58 | Chief Executive Officer | Sell | 10,000 | $30.15 | $301,511.36 | -0.4% | +18.0% | +125.8% | |
| Feb 5, 2025 | Dambkowski Carl51 | Chief Medical Officer | Sale+OE | 3,520 | $40.69 | $143,228.80 | -1.4% | -13.9% | +50.3% | |
| Feb 5, 2025 | Henderson Michael Thomas58 | Chief Executive Officer | Sell | 15,000 | $40.58 | $608,700.00 | -1.1% | -13.9% | +50.3% | |
| Jan 8, 2025 | Henderson Michael Thomas58 | Chief Executive Officer | Sell | 15,000 | $48.85 | $732,692.88 | -0.6% | -41.5% | +57.4% | |
| Jan 2, 2025 | Dambkowski Carl51 | Chief Medical Officer | Sale+OE | 4,085 | $46.94 | $191,739.64 | -0.5% | -19.8% | +60.7% | |
| Dec 12, 2024 | McKenna Mark C. | Director | Buy | 20,000 | $49.54 | $990,775.00 | +266.7% | -13.1% | +73.9% | |
| Dec 11, 2024 | Dambkowski Carl51 | Chief Medical Officer | Sale+OE | 4,540 | $48.76 | $221,362.70 | -0.9% | -17.4% | +56.9% |